We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+13.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.1B
AUM Growth
+$2.28B
Cap. Flow
+$553M
Cap. Flow %
3.24%
Top 10 Hldgs %
20.87%
Holding
2,825
New
311
Increased
1,187
Reduced
1,145
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 9.45%
2 Consumer Discretionary 4.97%
3 Healthcare 4.39%
4 Financials 4.25%
5 Communication Services 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PZG icon
2676
Paramount Gold Nevada
PZG
$130M
$20K ﹤0.01%
+16,710
New +$18.9K
VERO
2677
DELISTED
Venus Concept
VERO
$20K ﹤0.01%
+68
New +$25.4K
TXMD icon
2678
TherapeuticsMD
TXMD
$24.1M
$19K ﹤0.01%
312
+16
+5% +$1.09K
HIL
2679
DELISTED
Hill International, Inc. Common Stock
HIL
$19K ﹤0.01%
+10,000
New +$16.4K
TTOO
2680
DELISTED
T2 Biosystems, Inc
TTOO
$18K ﹤0.01%
3
+1
+50% +$6.12K
CCO icon
2681
Clear Channel Outdoor Holdings
CCO
$1.23B
$17K ﹤0.01%
10,000
-101,067
-91% -$127K
CRVO icon
2682
CervoMed
CRVO
$41.5M
$17K ﹤0.01%
277
REI icon
2683
Ring Energy
REI
$354M
$16K ﹤0.01%
24,500
-566
-2% -$373
TYME
2684
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$16K ﹤0.01%
13,000
GAU
2685
Galiano Gold
GAU
$546M
$15K ﹤0.01%
13,559
RAVE icon
2686
RAVE Restaurant Group
RAVE
$43.9M
$14K ﹤0.01%
15,575
USWS
2687
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$13K ﹤0.01%
1,481
+719
+94% +$5.67K
PULM icon
2688
Pulmatrix
PULM
$5.84M
$12K ﹤0.01%
510
PVL
2689
Permianville Royalty Trust
PVL
$57.8M
$10K ﹤0.01%
13,785
-4,000
-22% -$2.64K
RMTI icon
2690
Rockwell Medical
RMTI
$29.6M
$10K ﹤0.01%
+94
New +$10.5K
SONM icon
2691
DNA X Inc
SONM
$5.16M
$7K ﹤0.01%
6
NEOS
2692
DELISTED
Neos Therapeutics, Inc
NEOS
$6K ﹤0.01%
+10,000
New +$6.18K
ASRT
2693
DELISTED
Assertio
ASRT
$5K ﹤0.01%
+211
New +$6.56K
TRAW icon
2694
Traws Pharma
TRAW
$8.12M
$5K ﹤0.01%
+29
New +$3.37K
NAK
2695
Northern Dynasty Minerals
NAK
$953M
$3K ﹤0.01%
10,000
-15,000
-60% -$10.9K
APLE icon
2696
Apple Hospitality REIT
APLE
$3.71B
-11,070
Closed -$106K
ARDC
2697
Are Dynamic Credit Allocation Fund
ARDC
$298M
-32,982
Closed -$418K
AROW icon
2698
Arrow Financial
AROW
$725M
-21,934
Closed -$504K
ASPN icon
2699
Aspen Aerogels
ASPN
$510M
-58,586
Closed -$642K
AUGZ icon
2700
TrueShares Structured Outcome August ETF
AUGZ
$43.8M
-40,008
Closed -$1.02M

Similar funds

Cambridge Investment Research Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Cambridge Investment Research Advisors held 2,825 positions worth $17.1B, up 15% from $14.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $553M of net new capital in Q4 2020, opening 311 new positions and adding to 1,187 existing holdings. Its largest new stake was iPath Shiller CAPE ETN: 348,970 shares worth $6.21M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.8% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $30.8M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2020 buy was iPath Shiller CAPE ETN: 348,970 shares worth $6.21M.
  • Cambridge Investment Research Advisors added most to Vanguard Total International Stock ETF in Q4 2020, an estimated $80.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2020 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $30.8M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2020 Corporate Bond ETF in Q4 2020, selling an estimated $10.8M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $17.1B portfolio in Q4 2020.
  • Cambridge Investment Research Advisors opened 311 new positions and closed 119 in Q4 2020.
  • Cambridge Investment Research Advisors's portfolio value rose 15% quarter-over-quarter to $17.1B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.